Shelter Pharma

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013V01011
  • NSEID:
  • BSEID: 543963
INR
37.60
-1.3 (-3.34%)
BSENSE

Dec 05

BSE+NSE Vol: 21000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 26.58% vs 10.71% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 17.44% vs 5.47% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 152.27% vs 168.02% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 16.73% vs 19.10% in Mar 2024

Compare Profit and Loss Results of Shelter Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
50.00
33.00
17.00
51.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
50.00
33.00
17.00
51.52%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
37.00
15.00
22.00
146.67%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
3.00
-2.00
-66.67%
Operating Expenses
0.00
3.00
-3.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
40.00
29.00
11.00
37.93%
Operating Profit (PBDIT) excl Other Income
10.00
4.00
6.00
150.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
10.00
6.00
4.00
66.67%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
9.00
6.00
3.00
50.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
9.00
5.00
4.00
80.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
5.00
4.00
80.00%
Provision for Tax
2.00
1.00
1.00
100.00%
Profit After Tax
7.00
4.00
3.00
75.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
11.00
28.00
-17.00
-60.71%
Profit Available for appropriations
18.00
32.00
-14.00
-43.75%
Appropriations
18.00
32.00
-14.00
-43.75%
Equity Dividend (%)
0%
20%
-20.00
Earnings Per Share
6.26
13.36
-7.10
-53.14%
Profit And Loss - Net Sales
Net Sales 50.66 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.58% vs 10.71% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.44% vs 5.47% in Mar 2024

Profit And Loss - Interest
Interest 0.13 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 152.27% vs 168.02% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 7.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.73% vs 19.10% in Mar 2024